Influx Healthtech IPO is a book-built issue IPO, aiming to raise ₹58.57 crore. It is a combination of fresh issue of 50.00 lakh shares aggregating to ₹48.00 crores and an offer for sale of 11.00 lakh shares aggregating to ₹10.56 crores. The bidding window was open from June 18, 2025, to June 20, 2025, with the IPO allotment to be finalised on June 23, 2025. Influx Healthtech is scheduled to list on NSE SME on June 25, 2025.
The IPO was priced at a range of ₹91 – ₹96 per share with a lot size of 1200 shares. The public issue received bids for 81,71,71,200 shares against 40,58,400 shares available, resulting in an overall subscription of 201.35 times. NIIs led the response, subscribing 481.10 times their quota, followed by QIBs at 137.87 times.
Influx Healthtech' ₹58.57 crore IPO, priced between ₹91 – ₹96 per share, was subscribed 201.35 times overall. The IPO is a combination of fresh issue of 50.00 lakh shares aggregating to ₹48.00 crores and an offer for sale of 11.00 lakh shares aggregating to ₹10.56 crores. Bidding took place from June 18 to June 20, 2025, with the Influx Healthtech IPO allotment status on June 23, 2025. Retail investors subscribed 117.68 and NIIs 481.10 times. Listing is expected on June 25, 2025.
The table below breaks down the Influx Healthtech share allocation for different categories, highlighting the number of shares and their percentage of the total issue. However, the key focus remains on the quotas allocated to retail investors and HNIs, as they are the most relevant for individual investors.
| Investor Category | Shares Offered |
| Market Maker Shares Offered | 3,06,000 (4.78%) |
| Anchor Investor Shares Offered | 17,36,400 (27.10%) |
| QIB (Ex. Anchor) Shares Offered | 11,59,200 (18.09%) |
| NII (HNI) Shares Offered | 8,70,000 (13.58%) |
| Retail Shares Offered | 20,29,200 (31.67%) |
| Total Shares Offered | 64,06,800 (100.00%) |
Data Source: NSE
| Category | Subscription (times) |
| Qualified Institutional Buyers | 137.87 |
| Non-Institutional Investors | 481.10 |
| Retail Individual Investors | 117.68 |
| Total shares | 201.35 |
Note: The subscription details are as of June 20, 2025
Influx Healthtech Limited was originally incorporated as Influx Healthtech Private Limited on 28 September 2020 under the Companies Act, 2013. It was subsequently converted into a public limited company and renamed Influx Healthtech Limited on 23 May 2022.
The company operates as a Contract Development and Manufacturing Organisation, specialising in the production of dietary and nutritional supplements, cosmetics, Ayurvedic and herbal formulations, veterinary feed supplements, homecare products, and active pharmaceutical ingredients. Its product portfolio includes tablets, capsules, injectables, oral dispersible films, protein bars, and ready-to-drink nutraceutical beverages.
Influx Healthtech manages three manufacturing facilities in Thane, Maharashtra, with a combined area of approximately 36,676 square feet. These facilities are certified to international standards, including GMP, HACCP, ISO 22000, and Halal, ensuring high levels of quality, safety, and regulatory compliance.
The company’s operations are primarily focused within India, with a strong presence in Maharashtra, Gujarat, and Karnataka. Its customer base spans across B2B clients in the health, wellness, and pharmaceutical sectors, with a growing emphasis on private label manufacturing and export opportunities.
Know more about IPO allotment status and check your application details online for the latest updates on share allocation.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jun 20, 2025, 6:27 PM IST
Akshay Shivalkar
Akshay Shivalkar is a financial content specialist who strategises and creates SEO-optimised content on the stock market, mutual funds, and other investment products. With experience in fintech and asset management, he simplifies complex financial concepts to help investors make informed decisions through his writing.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
